Paxlovid is an antiviral combination therapy that can reduce the risk of COVID-19 causing severe illness, hospitalization and ...

COVID-19 is rising in prevalence in many states nationally following the July 4 holiday week, but the role of the main therapy to treat it—the antiviral drug Paxlovid—is less clear.

The interview with Dr Asad Khan on long Covid (Solidarity 747-748) highlights the contribution to the growth in mental ill-health of widespread long Covid, which affects hundreds of millions of ...

COVID-19 cases are rising in more than half of states. Is the US in a summer wave? What to know about COVID trends and ...

Two new COVID-19 variants are spreading through the U.S., and medical providers in Connecticut are expecting an uptick in cases in the coming weeks.

These five blue-chip dividend stocks have had a tough 2025 but are solid long-term buys for growth and income investors.

Here are five high-yield dividend stocks that offer passive income and solid entry points that investors can buy and forget ...

The condition known as long COVID may be more common than people think, according to a new study led by Oregon Health & Science University researchers.

Social risk factors significantly increase the likelihood of developing long COVID, highlighting the urgent need for ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.